enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Gastric balloon - Wikipedia

   en.wikipedia.org/wiki/Gastric_balloon

   The non-endoscopic gastric balloon capsule is swallowed for placement and once in the stomach is filled with saline liquid. After 16 weeks, the non-endoscopic gastric balloon then automatically deflates and passes naturally at the end of placement. A recent meta analysis of 6 studies found the balloon was a safe device offering effective weight ...

3. A swallowable balloon promises weight loss similar to popular ...

   www.aol.com/news/swallowable-balloon-promises...

   800-290-4726 more ways to reach us. Sign in. Mail. 24/7 Help. ... Sullivan is leading a clinical trial, sponsored by Allurion Technologies, designed to support approval for the balloon from the ...

4. List of clinical trial registries - Wikipedia

   en.wikipedia.org/wiki/List_of_clinical_trial...

   The DRKS is an open access, free of charge online register for clinical trials and is available both in English and German. DRKS is part of the WHO's ICTRP. The DRKS works with two partner registries in Germany, DeReG (German Registry for Somatic Gene-Transfer Trials) and Clinical Trial Registry of the University Medical Center Freiburg. [4]

5. Bariatric surgery - Wikipedia

   en.wikipedia.org/wiki/Bariatric_surgery

   [75] [76] The balloon can be left in the stomach for a maximum of 6 months and results in weight loss of 3 BMI or 3–8 kg within several study ranges. [75] [76] Weight loss with the gastric balloon tends to be more modest than other interventions. The intragastric balloon may be used before another bariatric surgery to assist the patient in ...

6. Management of obesity - Wikipedia

   en.wikipedia.org/wiki/Management_of_obesity

   A treatment involving the placement of an intragastric balloon via gastroscopy has shown promise. One type of balloon led to a weight loss of 5.7 BMI units over 6 months or 14.7 kg (32 lb). Regaining lost weight is common after removal, however, and 4.2% of people were intolerant of the device. [91]

7. Bristol-Myers Squibb’s Opdivo Receives US FDA Approval For ...

   www.aol.com/news/bristol-myers-squibb-opdivo...

   Bristol-Myers Squibb has received approval from the US Food and Drug Administration for Opdivo in combination with fluoropyrimidine- and platinum-containing chemotherapy to treat gastric cancer ...

8. US FDA declines to approve Astellas' gastric cancer drug - AOL

   www.aol.com/news/us-fda-declines-approve-astella...

   800-290-4726 more ways to reach us. Sign in. Mail. 24/7 Help. For premium support please call: 800-290-4726 more ways ... has declined to approve its experimental drug to treat a type of gastric ...

9. Cannon-Washburn Hunger Experiment - Wikipedia

   en.wikipedia.org/wiki/Cannon-Washburn_Hunger...

   To test the hypothesis, Cannon designed an innovative experiment in which A.L. Washburn swallowed a deflated rubber balloon attached to a tube. Once the balloon was inside Washburn's stomach, it was inflated. The pressure of the balloon against the stomach walls was used to measure the strength of contractions.